M Hosoi

438 total citations
25 papers, 374 citations indexed

About

M Hosoi is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M Hosoi has authored 25 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Cardiology and Cardiovascular Medicine and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M Hosoi's work include Receptor Mechanisms and Signaling (8 papers), Renin-Angiotensin System Studies (5 papers) and Nitric Oxide and Endothelin Effects (3 papers). M Hosoi is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), Renin-Angiotensin System Studies (5 papers) and Nitric Oxide and Endothelin Effects (3 papers). M Hosoi collaborates with scholars based in Japan, Italy and United States. M Hosoi's co-authors include Kenjiro Yamamoto, S Kim, Peter Brecher, Hideo Himeno, Aram V. Chobanian, Diane Crawford, H Morii, Yoshiki Nishizawà, K Murakami and Kyoko Kogawa and has published in prestigious journals such as Journal of Biological Chemistry, Circulation Research and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

M Hosoi

25 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M Hosoi Japan	13	204	120	117	63	59	25	374
Kojiro Ichikawa Japan	11	165 0.8×	62 0.5×	95 0.8×	51 0.8×	51 0.9×	14	390
Nathan Rehmer United States	8	186 0.9×	86 0.7×	143 1.2×	71 1.1×	72 1.2×	8	400
Shin-ichiro Mita Japan	8	135 0.7×	130 1.1×	115 1.0×	72 1.1×	108 1.8×	11	369
Toyohisa Jinno Japan	9	219 1.1×	113 0.9×	95 0.8×	94 1.5×	45 0.8×	12	403
Yoshie Arai Japan	7	187 0.9×	91 0.8×	110 0.9×	42 0.7×	24 0.4×	9	305
G.N. Jyothirmayi United States	9	334 1.6×	101 0.8×	244 2.1×	67 1.1×	82 1.4×	20	669
Narimasa Takayama Japan	10	239 1.2×	94 0.8×	61 0.5×	67 1.1×	55 0.9×	12	403
Maura Knapp United States	5	118 0.6×	139 1.2×	50 0.4×	44 0.7×	52 0.9×	6	339
Christiné S. Rigsby United States	10	87 0.4×	154 1.3×	157 1.3×	100 1.6×	72 1.2×	11	410
Darren R. Davis Australia	9	170 0.8×	60 0.5×	107 0.9×	32 0.5×	24 0.4×	11	376

Countries citing papers authored by M Hosoi

Since Specialization

Citations

This map shows the geographic impact of M Hosoi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Hosoi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Hosoi more than expected).

Fields of papers citing papers by M Hosoi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Hosoi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Hosoi. The network helps show where M Hosoi may publish in the future.

Co-authorship network of co-authors of M Hosoi

This figure shows the co-authorship network connecting the top 25 collaborators of M Hosoi. A scholar is included among the top collaborators of M Hosoi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Hosoi. M Hosoi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ledda, A, G Belcaro, Mark Dugall, et al.. (2017). A natural pharma standard supplement formulation to control treatment-related toxicity and oxidative stress in genitourinary cancer: a preliminary study.. PubMed. 21(18). 4196–4202. 8 indexed citations

Hu, Shengqing, Umberto Cornelli, R Luzzi, et al.. (2015). Effects of Pycnogenol® on endothelial dysfunction in borderline hypertensive, hyperlipidemic, and hyperglycemic individuals: the borderline study.. PubMed. 34(1). 43–52. 14 indexed citations

Pellegrini, L, G Belcaro, Mark Dugall, et al.. (2015). Management of functional, hepatic damage after chemotherapy with Liverubin (pharma-standard silymarin).. PubMed. 1 indexed citations

Belcaro, Gianni, E. Ippolito, Mark Dugall, et al.. (2015). Pycnogenol® and Centella asiatica in the management of asymptomatic atherosclerosis progression.. PubMed. 34(2). 150–7. 18 indexed citations

Pellegrini, L, G Belcaro, Mark Dugall, et al.. (2015). Supplementary management of functional, hepatic damage with Liverubin (pharma-standard Silymarin). A 3-month registry.. PubMed. 1 indexed citations

Okumura, Michiaki, Masahiro Masada, Yuichi Yoshida, et al.. (2006). Decrease in tetrahydrobiopterin as a possible cause of nephropathy in type II diabetic rats. Kidney International. 70(3). 471–476. 30 indexed citations

Yamamoto, Tohru, Eiji Yamato, H Taniguchi, et al.. (2006). Stimulation of cAMP signalling allows isolation of clonal pancreatic precursor cells from adult mouse pancreas. Diabetologia. 49(10). 2359–2367. 22 indexed citations

Yamagami, Keiko, M Hosoi, Tohru Yamamoto, et al.. (2004). Coronary arterial calcification is associated with albuminuria in type 2 diabetic patient. Diabetes Obesity and Metabolism. 7(4). 390–396. 12 indexed citations

Yamamoto, Tohru, Tomonobu Satô, M Hosoi, et al.. (2003). Aldose reductase gene polymorphism is associated with progression of diabetic nephropathy in Japanese patients with type 1 diabetes mellitus. Diabetes Obesity and Metabolism. 5(1). 51–57. 6 indexed citations

10.

Taniwaki, H., Takahiko Kawagishi, M. Emoto, et al.. (1999). Association of ACE gene polymorphism with arterial stiffness in patients with type 2 diabetes.. Diabetes Care. 22(11). 1858–1864. 44 indexed citations

11.

Nishizawà, Yoshiki, Hidenori Koyama, Atsushi Shioi, et al.. (1995). Parathyroid hormone-related peptide and models of vascular disease: its expression and action in vascular smooth muscle cells.. PubMed. 21(1-3). 152–6. 7 indexed citations

12.

Himeno, Hideo, Diane Crawford, M Hosoi, Aram V. Chobanian, & Peter Brecher. (1994). Angiotensin II alters aortic fibronectin independently of hypertension.. Hypertension. 23(6_pt_2). 823–826. 39 indexed citations

13.

Hosoi, M, et al.. (1993). Selective induction of an embryonic fibronectin isoform in the rat aorta in vitro.. Circulation Research. 73(4). 689–695. 15 indexed citations

14.

Hosoi, M, S Kim, Tsutomu Tabata, et al.. (1992). Evidence for the presence of differently glycosylated forms of prorenin in the plasma of anephric man.. The Journal of Clinical Endocrinology & Metabolism. 74(3). 680–684. 11 indexed citations

15.

Hosoi, M, et al.. (1992). Effects of prorenin on blood pressure and plasma renin concentrations in stroke-prone spontaneously hypertensive rats. American Journal of Physiology-Endocrinology and Metabolism. 262(2). E234–E239. 9 indexed citations

16.

Kim, S, et al.. (1992). Adrenal and circulating renin-angiotensin system in stroke-prone hypertensive rats.. Hypertension. 20(3). 280–291. 57 indexed citations

17.

Hosoi, M, et al.. (1991). Amino-terminal amino acid sequence and heterogeneity in glycosylation of rat renal renin.. Journal of Biological Chemistry. 266(11). 7044–7050. 20 indexed citations

18.

Hosoi, M, et al.. (1990). Conversion to renin of exogenously administered recombinant human prorenin in liver and kidney of monkeys. American Journal of Physiology-Endocrinology and Metabolism. 258(3). E451–E458. 12 indexed citations

19.

Hosoi, M, et al.. (1989). Modification of glycosylation of renin in sodium-depleted and captopril-treated rats. American Journal of Physiology-Endocrinology and Metabolism. 256(6). E798–E804. 13 indexed citations

20.

Hosoi, M, et al.. (1989). [Primary osteogenic sarcoma of the breast. Report of a case].. PubMed. 90(8). 1262–5. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact